# FDA Inspection 1089055 - Selwyn Spangenthal, M.D. - April 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/selwyn-spangenthal-md/9372bc75-aab7-4b9e-b3d3-47390bf02259
Source feed: FDA_Inspections

> FDA Inspection 1089055 for Selwyn Spangenthal, M.D. on April 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089055
- Company Name: Selwyn Spangenthal, M.D.
- Inspection Date: 2019-04-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1156995 - 2021-11-08](https://www.keypedia.com/records/fda_inspections/selwyn-spangenthal-md/d83f5348-f873-4bfa-ba1a-386f2b3d6216)

Company: https://www.keypedia.com/companies/selwyn-spangenthal-md/818d953b-e600-45b9-9dac-091dae301b03

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c